These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6893618)

  • 1. Comparative bioavailability study of theophylline tablets marketed in Australasia.
    Charles BG; Ravenscroft PJ; Bochner F
    Med J Aust; 1980 Sep; 2(5):264-6. PubMed ID: 6893618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and pharmacological effects of two slow-release theophylline preparations: intrasubject tablet-to-tablet variability.
    Rivera-Calimlim L; Calimlim JF; Liang R; Lasagna L; Diamond GL
    J Asthma; 1986; 23(3):113-22. PubMed ID: 3528119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bioavailability of theophylline from hydroalcoholic and alcohol-free preparations.
    Sligo JH; Charles BG; Ravenscroft PJ
    Med J Aust; 1981 Oct; 2(8):410-1. PubMed ID: 7321973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation.
    Svedmyr K; Mellstrand T; Svedmyr N
    Allergy; 1982 Feb; 37(2):111-7. PubMed ID: 7137520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the absorption from some commercial enteric-release theophylline products.
    Upton RA; Powell JR; Guentert TW; Thiercelin JF; Sansom L; Coates PE; Riegelman S
    J Pharmacokinet Biopharm; 1980 Apr; 8(2):151-64. PubMed ID: 7431220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bio-availability of theophylline whole and halved sustained-release tablets.
    Müller FO; Hundt HK; Luus HG; van Dyk M; Groenewoud G; van der Meer MJ; Steinijans VW
    S Afr Med J; 1987 Aug; 72(3):175-8. PubMed ID: 3299763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.
    Coulthard KP; Birkett DJ; Lines DR; Grgurinovich N; Grygiel JJ
    Eur J Clin Pharmacol; 1983; 25(5):667-72. PubMed ID: 6686557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic pharmacokinetics of asymmetrical doses of slow release choline theophyllinate in asthma.
    Hibberd SG; Alveyn C; Coombes EJ; Holgate ST
    Br J Clin Pharmacol; 1986 Sep; 22(3):337-41. PubMed ID: 3768245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of four slow-release theophylline formulations in the beagle dog.
    Koritz GD; McKiernan BC; Neff-Davis CA; Munsiff IJ
    J Vet Pharmacol Ther; 1986 Sep; 9(3):293-302. PubMed ID: 3761420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.
    Leeds NH; Gal P; Purohit AA; Walter JB
    J Clin Pharmacol; 1982 Apr; 22(4):196-200. PubMed ID: 7096605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline concentrations in serum and saliva after oral microcrystalline and sustained-release preparations in asthmatics.
    Munch EP; Søndergaard I; Weeke B
    Allergy; 1981 Feb; 36(2):89-98. PubMed ID: 7235205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.
    Rogers RJ; Kalisker A; Wiener MB; Szefler SJ
    J Pediatr; 1985 Mar; 106(3):496-501. PubMed ID: 3973788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative bioavailability of sustained-release and conventional tablets of hydroxyethyltheophylline in man.
    Sharma PL; Sharma RM
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):394-6. PubMed ID: 583044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption of sustained-release theophylline tablets.
    Fagerström PO; Heintz L
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):359-62. PubMed ID: 6885207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind comparative trial of Nuelin Depot and TheoDur with adjusted dosage in asthmatic adults.
    Langaker KE; Osmundsen K; Bredesen JE; Lunde PK
    Allergy; 1981 Oct; 36(7):501-5. PubMed ID: 6121518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of food and tablet division on the absorption of a sustained-release preparation of theophylline.
    Shenfield GM; Hudson BJ; Boutagy JS; Munro IA; Vandenberg RA
    Med J Aust; 1984 Apr; 140(8):477-9. PubMed ID: 6708867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Thürkow-Luikens AJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation of product formulation to absorption of oral theophylline.
    Weinberger M; Hendeles L; Bighley L
    N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.